160 related articles for article (PubMed ID: 178329)
21. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
[TBL] [Abstract][Full Text] [Related]
22. Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy.
Kissebah AH; Alfarsi S; Adams PW; Seed M; Folkard J; Wynn V
Atherosclerosis; 1976; 24(1-2):199-218. PubMed ID: 182185
[TBL] [Abstract][Full Text] [Related]
23. Demonstration of an abnormality of C apoprotein of very low density lipoprotein in patients with gout.
Macfarlane DG; Midwinter CA; Dieppe PA; Bolton CH; Hartog M
Ann Rheum Dis; 1985 Jun; 44(6):390-4. PubMed ID: 4015201
[TBL] [Abstract][Full Text] [Related]
24. Apoprotein profile of plasma and chylous ascites lipoproteins.
Malmendier CL; Amerijckx JP
Clin Chim Acta; 1976 May; 68(3):259-69. PubMed ID: 179735
[TBL] [Abstract][Full Text] [Related]
25. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
Atger V; Beyne P; Frommherz K; Roullet JB; Drüeke T
Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681
[TBL] [Abstract][Full Text] [Related]
26. Immunoturbidimetric techniques for quantifying apolipoproteins CII and CIII.
Rifai N; Silverman LM
Clin Chem; 1986 Oct; 32(10):1969-72. PubMed ID: 3093121
[TBL] [Abstract][Full Text] [Related]
27. Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins.
Havel RJ; Kane JP
Proc Natl Acad Sci U S A; 1973 Jul; 70(7):2015-9. PubMed ID: 4352966
[TBL] [Abstract][Full Text] [Related]
28. Chylomicron and very low-density lipoprotein apolipoprotein B metabolism: mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia.
Hazzard WR; Kushwaha RS; Applebaum-Bowden D; Haffner SM; Steinmetz A; Foster DM
Metabolism; 1984 Oct; 33(10):873-81. PubMed ID: 6482732
[TBL] [Abstract][Full Text] [Related]
29. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins.
Utermann G; Jaeschke M; Menzel J
FEBS Lett; 1975 Aug; 56(2):352-5. PubMed ID: 169165
[No Abstract] [Full Text] [Related]
30. Effect of human high density lipoproteins, anti-apolipoproteins CII and CIII, and hydrolysis of very low density lipoprotein (VLDL) cholesterol ester on VLDL catabolism in vitro.
Liu BW; Hynd BA; Kashyap ML
Biochem Biophys Res Commun; 1984 Jun; 121(3):946-52. PubMed ID: 6588972
[TBL] [Abstract][Full Text] [Related]
31. [Dynamic behavior of apoproteins of human plasma very low density lipoproteins and lipolysis regulation].
Dergunov AD; Shuvaev VV; Perova NV
Biokhimiia; 1990 Jan; 55(1):134-46. PubMed ID: 2160840
[TBL] [Abstract][Full Text] [Related]
32. The metabolism of low density lipoprotein in endogenous hypertriglyceridaemia.
Sigurdsson G; Nicoll A; Lewis B
Eur J Clin Invest; 1976 Mar; 6(2):151-8. PubMed ID: 177294
[TBL] [Abstract][Full Text] [Related]
33. Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL.
Murdoch SJ; Breckenridge WC
Biochim Biophys Acta; 1996 Oct; 1303(3):222-32. PubMed ID: 8908157
[TBL] [Abstract][Full Text] [Related]
34. Relation of abnormal composition of lipoproteins to HbA1c levels in non-insulin dependent diabetes.
Sánchez-Cabezudo M; Ródenas S; Cuesta C
Rev Esp Fisiol; 1994 Sep; 50(3):145-51. PubMed ID: 7886271
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein composition as a component in the lipoprotein clearance defect in experimental diabetes.
O'Looney P; Irwin D; Briscoe P; Vahouny GV
J Biol Chem; 1985 Jan; 260(1):428-32. PubMed ID: 3965456
[TBL] [Abstract][Full Text] [Related]
36. Lipid metabolism in pregnancy. IV. C Apoprotein changes in very low and intermediate density lipoproteins.
Montes A; Knopp RH
J Clin Endocrinol Metab; 1977 Nov; 45(5):1060-3. PubMed ID: 925131
[TBL] [Abstract][Full Text] [Related]
37. Low density lipoprotein metabolism in type IV and type V hyperlipoproteinemia.
Brook JG; Torsvik H; Lees RS; McCluskey MA; Feldman HA
Metabolism; 1979 Jan; 28(1):4-8. PubMed ID: 215869
[TBL] [Abstract][Full Text] [Related]
38. The role of high density lipoprotein apolipoprotein CII in triglyceride metabolism.
Kashyap ML; Srivastava LS; Hynd BA; Perisutti G; Brady DW; Gartside P; Glueck CJ
Lipids; 1978 Dec; 13(12):933-42. PubMed ID: 220489
[No Abstract] [Full Text] [Related]
39. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
40. Effect of clofibrate on the composition of very low and low density lipoprotein subfractions in type III hyperlipoproteinaemia.
Ballantyne D; Ballantyne FC; Stromberg P; Third JL; Bedford DK
Clin Chim Acta; 1978 Feb; 83(1-2):117-22. PubMed ID: 202421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
